Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolution Group PLS Regulatory News (FAN)

Share Price Information for Volution Group PLS (FAN)

Share Price is delayed by 15 minutes
Get Live Data
609.00    8.00 (1.33%)
Bid:
609.00
Ask:
610.00
Spread: 1.00 (0.164%)
Market Cap: £1.21b
FAN Live PriceLast checked at - London Stock Exchange

Intraday Volution Group PLS Share Chart

Form 8.3 - Volution Group PLC

11 Nov 2015 16:04

RNS Number : 4111F
Neptune Investment Management Ltd
11 November 2015
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Neptune Investment Management Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

 

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Volution Group PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

Held 11/11/15

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,523,412

2.76

n/a

(2) Derivatives (other than options):

n/a

n/a

(3) Options and agreements to purchase/sell:

n/a

n/a

 

TOTAL:

5,523,412

2.76

n/a

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

N/A

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

N/A

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

11th November 2015

Contact name:

Kieran Raymond

Telephone number:

0203 249 0197

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETEASFFFSXSFFF
Date   Source Headline
2nd Apr 20204:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
2nd Apr 20207:00 amRNSCOVID-19 Trading Update
25th Mar 20207:00 amRNSCOVID-19 update & suspension of interim dividend
18th Mar 20204:10 pmRNSDirector/PDMR Shareholding
16th Mar 20207:00 amRNSInterim Results for 6 months ended 31 Jan 2020
2nd Mar 20207:00 amRNSVolution announces new reporting structure
20th Feb 20206:00 pmRNSNotice of Interim Results
17th Feb 20205:05 pmRNSHolding(s) in Company
31st Jan 20204:36 pmRNSTotal Voting Rights
24th Jan 202010:36 amRNSDirector and PCA Dealing
24th Jan 20208:28 amRNSProposed Director and PCA Dealing
20th Jan 20207:00 amRNSAppointment of new Chairman
10th Jan 20207:00 amRNSAppointment of new Chairman
3rd Jan 20204:51 pmRNSHolding(s) in Company
17th Dec 20198:58 amRNSDirector Declaration
12th Dec 20194:27 pmRNSResult of AGM
4th Dec 20197:00 amRNSInvestor & Analyst Event
21st Nov 20193:08 pmRNSHolding(s) in Company
20th Nov 20195:52 pmRNSHolding(s) in Company
4th Nov 20192:19 pmRNSTotal Voting Rights
25th Oct 20198:49 amRNSAnnual Financial Report & Notice of AGM
24th Oct 20194:55 pmRNSHolding(s) in Company
22nd Oct 20195:24 pmRNSHolding(s) in Company
18th Oct 20195:32 pmRNSDirector/PDMR Shareholding
16th Oct 20193:55 pmRNSDirector/PDMR Shareholding
9th Oct 20197:00 amRNSPreliminary Results for year ended 31 July 2019
12th Sep 20195:45 pmRNSNotice of Full Year Results
21st Aug 20195:27 pmRNSHolding(s) in Company
13th Aug 20197:00 amRNSTrading Update for year ended 31 July 2019
29th Jul 20192:04 pmRNSNotice of Trading Update
3rd Jul 20197:00 amRNSAppointment of Chief Financial Officer
24th May 201912:16 pmRNSDirector/PDMR Shareholding
10th Apr 20197:00 amRNSVolution Group appoints CFO Designate
18th Mar 20197:00 amRNSInterim Results for 6 months ended 31 Jan 2019
1st Mar 20197:00 amRNSAcquisition of Ventair Pty Ltd
18th Feb 20199:02 amRNSNotice of Interim Results
23rd Jan 20192:40 pmRNSDirector/PDMR Shareholding
21st Jan 201910:05 amRNSShare Purchase by Senior Independent Director
21st Jan 20197:00 amRNSVolution Group CFO to retire in 2019
17th Jan 20194:56 pmRNSShare Purchase by Senior Independent Director
17th Jan 20193:05 pmRNSShare Purchase by CEO
2nd Jan 20192:23 pmRNSTotal Voting Rights
12th Dec 20182:17 pmRNSResult of AGM
28th Nov 20188:36 amRNSDirector/PDMR Shareholding
19th Nov 20185:30 pmRNSDirector/PDMR Shareholding
29th Oct 20183:37 pmRNSShare Purchase by Non-Executive Director
29th Oct 20189:40 amRNSAnnual Financial Report
17th Oct 20185:35 pmRNSDirector/PDMR Shareholding
11th Oct 20182:50 pmRNSShare purchase by CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.